Cervical Health
Leading cervical cancer screening
For over 25 years, Hologic has been at the forefront of cervical cancer screening. Pap and human papillomavirus (HPV) testing are an essential component of our efforts in women’s health. With more than 1 billion tests performed worldwide2, our ThinPrep® Pap test has become the most widely used liquid-based cytology test2—helping healthcare providers detect the presence of abnormal cervical cells.3 While other HPV assays target DNA, our Aptima® HPV assays identify high-risk HPV mRNA that is indicative of the HPV infections most likely to lead to cervical disease. Furthermore, our Aptima HPV 16 18/45 genotype assay allows for the detection of HPV types 16, 18 and 45, which together are are associated with over 80% of all squamous cell carcinomas and 92% of adenocarcinomas.4
Hologic’s Offerings
Our suite of testing tools leads the market in accuracy and sensitivity, providing the insights you need for your patient’s best care.
ThinPrep® Pap Test
ThinPrep® Pap Test
The ThinPrep Vial provides out-of-the-vial testing which minimizes the number of samples required for multiple test results.
Aptima® HPV Assay & Aptima® HPV 16/18/45 genotype Assay
Aptima® HPV Assay & Aptima® HPV 16/18/45 genotype Assay
Detects high-risk HPV types with high sensitivity and specificity to identify women at risk for cervical disease.
Cervical Screening Strategies
Cervical Screening Strategies
Explore U.S. cervical cancer screening guidelines and methods for early detection and patient care.
Let’s Connect
Have a question or need to talk to a Hologic team member? We’re here to help.